DE602004019206D1 - Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität - Google Patents
Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizitätInfo
- Publication number
- DE602004019206D1 DE602004019206D1 DE602004019206T DE602004019206T DE602004019206D1 DE 602004019206 D1 DE602004019206 D1 DE 602004019206D1 DE 602004019206 T DE602004019206 T DE 602004019206T DE 602004019206 T DE602004019206 T DE 602004019206T DE 602004019206 D1 DE602004019206 D1 DE 602004019206D1
- Authority
- DE
- Germany
- Prior art keywords
- inflammatory
- prophylaxis
- therapy
- inflammation
- medicine preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47246003P | 2003-05-22 | 2003-05-22 | |
US10/464,834 US20040115290A1 (en) | 2001-06-20 | 2003-06-18 | Modulation of inflammation by hops fractions and derivatives |
US10/464,410 US8142819B2 (en) | 2002-10-21 | 2003-06-18 | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US10/689,856 US7270835B2 (en) | 2001-06-20 | 2003-10-20 | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US10/774,048 US20040219240A1 (en) | 2001-06-20 | 2004-02-05 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
PCT/US2004/016043 WO2005039483A2 (en) | 2003-05-22 | 2004-05-21 | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004019206D1 true DE602004019206D1 (de) | 2009-03-12 |
Family
ID=34528371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004019206T Active DE602004019206D1 (de) | 2003-05-22 | 2004-05-21 | Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität |
Country Status (2)
Country | Link |
---|---|
US (1) | US20040219240A1 (de) |
DE (1) | DE602004019206D1 (de) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US20040115290A1 (en) | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US7901714B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US7270835B2 (en) * | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7815944B2 (en) * | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
WO2004037180A2 (en) | 2002-10-21 | 2004-05-06 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7811610B2 (en) * | 2003-05-22 | 2010-10-12 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
ES2557324T3 (es) * | 2004-02-23 | 2016-01-25 | Sss Acquisition, Llc | Alimentos que contienen ácidos de lúpulo y su utilización como suplementos en piensos |
US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
US20050192356A1 (en) | 2004-02-27 | 2005-09-01 | Babish John G. | Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
US20090274778A1 (en) * | 2004-11-13 | 2009-11-05 | Babish John G | Compositions Exhibiting Inhibition Of Cyclooxygenase-2 |
US20060177504A1 (en) * | 2005-02-08 | 2006-08-10 | Renjit Sundharadas | Combination pain medication |
MX2008001903A (es) | 2005-08-09 | 2008-04-16 | Metaproteomics Llc | Modulacion de proteina cinasa por medio de lupulos y productos de acacia. |
AU2012204133B2 (en) * | 2005-08-09 | 2013-09-19 | Metaproteomics, Llc | Protein kinase modulation by hops and acacia products |
FR2892635B1 (fr) * | 2005-10-28 | 2012-11-09 | Engelhard Lyon | Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage |
US20070154576A1 (en) * | 2005-12-09 | 2007-07-05 | Tripp Matthew L | Protein kinase modulation by hops and Acacia products |
DE102006010775A1 (de) * | 2006-03-08 | 2007-09-13 | Johann Berger | Gurtband, Verfahren und Nadel-Bandwebmaschine zur Herstellung desselben |
EP2626077A3 (de) * | 2007-03-19 | 2013-11-20 | Metaproteomics, LLC | Zusammensetzungen zur Förderung der Gesundheit von Knochen und Gelenken |
CA2686043A1 (en) | 2007-05-11 | 2008-11-20 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
US8388982B2 (en) * | 2008-11-19 | 2013-03-05 | Pacific Biosciences Of California, Inc. | Photo-induced damage mitigating agents and preparation and methods of use thereof |
US8410178B2 (en) | 2010-10-30 | 2013-04-02 | Kindex Therapeutics, Llc | CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods |
US20160101125A1 (en) * | 2013-05-29 | 2016-04-14 | Nestec S.A. | Compositions for use in cartilage breakdown |
CN103980104B (zh) | 2014-02-19 | 2015-10-28 | 广州英赛特生物技术有限公司 | 六氢β-酸单酯、内络盐或单酯盐及其做为动物饲料添加剂的应用 |
WO2020033796A1 (en) | 2018-08-10 | 2020-02-13 | Metagenics, Inc. | Method of treating inflammatory bowel disease |
CN114599665A (zh) | 2019-08-16 | 2022-06-07 | 应用分子转运公司 | 组合物、制剂及白细胞介素产生和纯化 |
CN112679355B (zh) * | 2020-12-23 | 2021-10-12 | 华南农业大学 | 一种7-醛基-9-异丁酰氧基-8-羟基百里酚其在制备抗菌剂或抗菌药物中的应用 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3933919A (en) * | 1964-12-15 | 1976-01-20 | Geoffrey Wilkinson | Hydroformylation of mono-α-olefins and mono-α-acetylenes |
GB1145240A (en) * | 1965-03-01 | 1969-03-12 | Kalamazoo Spice Extract Co | Hop flavours for malt beverages and the like |
US3720517A (en) * | 1970-12-21 | 1973-03-13 | Hamm T Brewing Co | Preparation of a fermented malt champagne |
US3932603A (en) * | 1971-05-28 | 1976-01-13 | General Foods Corporation | Oral preparations for reducing the incidence of dental caries |
US3965188A (en) * | 1972-01-10 | 1976-06-22 | Miller Brewing Company | Hop extract process and product |
CH617326A5 (de) * | 1975-12-04 | 1980-05-30 | Siegfried Ag | |
US4123561A (en) * | 1977-02-01 | 1978-10-31 | S.S. Steiner, Inc. | Method for processing hops for brewing |
US4401684A (en) * | 1981-10-01 | 1983-08-30 | Australian Hop Marketers Pty. Ltd. | Preservation of hops utilizing ascorbic acid |
BE896610A (fr) * | 1982-05-06 | 1983-08-16 | Hop Developments Ltd | Extraction d'une matiere vegetale en utilisant de l'anhydride carbonique |
US4644084A (en) * | 1984-01-25 | 1987-02-17 | Miller Brewing Company | Preparation of tetrahydroisohumulones |
GB2187755B (en) * | 1984-02-28 | 1990-03-28 | Kalamazoo Holdings Inc | Separation of the constituents of co2 hop extracts |
US4780463A (en) * | 1984-12-26 | 1988-10-25 | Analgesic Associates | Analgesic, anti-inflammatory and skeletal muscle relaxant compositions comprising non-steroidal anti-inflammatory drugs and musculoskeletal relaxants and methods of using same |
US4767640A (en) * | 1985-10-29 | 1988-08-30 | Miller Brewing Company | Light stable hop extracts and method of preparation |
US4692280A (en) * | 1986-12-01 | 1987-09-08 | The United States Of America As Represented By The Secretary Of Commerce | Purification of fish oils |
DE3712986A1 (de) * | 1987-04-16 | 1988-10-27 | Marbert Gmbh | Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt |
US5166449A (en) * | 1988-08-15 | 1992-11-24 | Kalamazoo Holdings, Inc. | Synthesis of hexahydrolupulone, novel forms thereof, and its use as a selective inhibitor of cell growth and multiplication |
US5082975A (en) * | 1988-08-15 | 1992-01-21 | Kalamazoo Holdings, Inc. | Synthesis of hexahydrolupulone, novel forms thereof, and its use as a selective inhibitor of cell growth and multiplication |
US5013571A (en) * | 1990-01-31 | 1991-05-07 | Pfizer Inc. | Methods for making tetrahydroisoalpha and hexahydroisoalpha acids |
DE59010282D1 (de) * | 1990-09-10 | 1996-05-15 | Fromm Mayer Bass Ltd | Verfahren zur Isomerisierung von Humulon in einem Kohlendioxid-Hopfenextrakt und ein Verfahren zur Gewinnung von Isohumulon daraus |
TW199905B (en) * | 1992-02-03 | 1993-02-11 | J E Siebel Sons Company Inc | Method and composition for enhancing foam properties of fermented malt beverages |
US5286506A (en) * | 1992-10-29 | 1994-02-15 | Bio-Technical Resources | Inhibition of food pathogens by hop acids |
US5296637A (en) * | 1992-12-31 | 1994-03-22 | Kalamazoo Holdings, Inc. | Production of odor-free tetrahydroisohumulates from alpha acids via their tetrahydrohumulates and subsequent isomerization |
JP2677762B2 (ja) * | 1994-04-08 | 1997-11-17 | 株式会社神戸製鋼所 | 油冷式圧縮機 |
DE69507185T2 (de) * | 1994-04-12 | 1999-09-09 | Hoechst Marion Roussel Inc | Arzneimittel zur Behandlung von Osteoporose |
US5827895A (en) * | 1996-02-27 | 1998-10-27 | Regents Of The University Of Minnesota | Hexahydrolupulones useful as anticancer agents |
US6020019A (en) * | 1996-03-26 | 2000-02-01 | Miller Brewing Company | Hydrogenation of hop soft resins using CO2 |
US6383527B1 (en) * | 1999-03-04 | 2002-05-07 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID |
US6129907A (en) * | 1999-08-04 | 2000-10-10 | Colgate Palmolive Company | Stable hydrogenated lupulone antibacterial oral compositions |
US6953593B2 (en) * | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
US6583322B1 (en) * | 2000-02-25 | 2003-06-24 | Kalamazoo Holdings, Inc. | Dihydro and hexahydro isoalpha acids having a high ratio of trans to cis isomers, production thereof, and products containing the same |
US20020086070A1 (en) * | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
US6391346B1 (en) * | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
-
2004
- 2004-02-05 US US10/774,048 patent/US20040219240A1/en not_active Abandoned
- 2004-05-21 DE DE602004019206T patent/DE602004019206D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
US20040219240A1 (en) | 2004-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004019206D1 (de) | Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität | |
CY2016031I2 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
NO20044054L (no) | Administrering av midler for behandling av betennelse | |
BR9710372A (pt) | Composto composi-Æo farmac-utica e processos para o tratamento de uma doen-a inflamatÄria e de doen-as mediadas pela cliclooxigenase | |
CL2003002353A1 (es) | Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic | |
ITMI20020756A1 (it) | Composizioni farmaceutiche topiche per il trattamento delle dermatiti | |
CY2013041I1 (el) | Φαρμακευτικες συνθεσεις περιλαμβανοντας δεξτρομεθορφανη και κινιδινη για την αγωγη νευρολογικων διαταραχων | |
ATE413178T1 (de) | 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen | |
DK1487541T3 (da) | Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme | |
ATE345136T1 (de) | Cysteinprotease-hemmer mit 2-cyano-4-amino- pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen | |
CY1108932T1 (el) | Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
DE602004010708D1 (de) | Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen | |
AU2003216586A8 (en) | Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
FI20011403A (fi) | Menetelmä ja koostumukset vatsan sairauksien hoitoon | |
ITRM20020014A0 (it) | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del | |
DE60218375D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen | |
AU2003235743A8 (en) | Topical application of alpha-dfmo and anti-inflammatory drug for treatment of actinic keratoses | |
ATE421357T1 (de) | Entzündungshemmende arzneizubereitungen zur entzündungsverminderung und die therapie oder die prophylaxe von der gastrischen toxizität | |
EE200300570A (et) | Imidasotriasinoonide derivaadid ja nende kasutamine põletikuliste protsesside ja/või immuunhaigustevastu | |
EE200200698A (et) | Ravimid neurodegeneratiivsete haiguste ennetamiseks ja raviks | |
AU2003252187A8 (en) | Topical composition for the treatment of inflammatory conditions of the skin | |
HN2002000129A (es) | Nuevos heterociclos 3 | |
HU0105291D0 (en) | Pharmaceutical compositions for the treatment of indigestion and related diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |